ArticleIndian journal of endocrinology and metabolism
Sarcopenic Obesity in Indian Adults with Type 2 Diabetes Mellitus: Prevalence and Associated Risk Factors.
Article in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Sarcopenia in Indian adults with type 2 diabetes: a systematic review and meta-analysis of prevalence and associated factors.BMJ open · 2026Pooled it
- Prevalence of sarcopenic obesity in adult patients with diabetes and associated factors: a systematic review and meta-analysis.Frontiers in nutrition · 2026Pooled it
- The Indian Obesity Paradox- Low in Muscle, High in Fat.Indian journal of endocrinology and metabolismArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sarcopenic obesity, a condition combining muscle loss and obesity, is common in older adults and increasingly seen in younger individuals due to various risk factors. This study aims to assess the prevalence of SO in Indian adults with T2DM and identify key risk factors to help in early detection and prevention. Methods: This cross-sectional observational study, conducted from October 2022 to July 2024 at a tertiary care hospital of Northern India, assessed the prevalence of sarcopenic obesity in Indian adults with Type 2 Diabetes Mellitus. Participants included obese T2DM patients over 40 years, excluding those with conditions like malignancies or chronic diseases. The diagnosis of sarcopenia was made based on the recommendations of the Asian Working Group for Sarcopenia (AWGS). Key assessments involved demographic data, metabolic and physical evaluations, and the use of the International Physical Activity Questionnaire (IPAQ) to categorize physical activity levels. Results: Data from 151 patients revealed a mean age of 57.2 ± 8.4 years, with an overall prevalence of sarcopenic obesity (SO) at 44%. SO was more prevalent in males (48.38%) compared to females (40.45%). SO was significantly associated with older age, low physical activity, poor glycemic control, insulin use, and the presence of diabetes complications. Conclusion: This study identifies a high prevalence of sarcopenic obesity (SO) in older Indian adults with Type 2 Diabetes. Key risk factors include low physical activity, poor glycemic control, insulin use, and diabetes-related complications, while hypertension and dyslipidemia were not significantly linked to SO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.